InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Morris Richard Steven, Chief Financial Officer. Officer active across 1 company, notably Passage BIO, Inc.. Cumulatively, 2 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €49k. History available since 21 May 2021. The latest transaction was disclosed on 21 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
2,171 shares@ US$13.818350.0% of flowCommon StockSEC:0001209191-21-035059
Ideal exit: 15 Feb 2022 (T+270)
2,171 shares@ US$13.81830.15% mcap50.0% of flowCommon StockSEC:0001209191-21-035059:0
Ideal exit: 15 Feb 2022 (T+270)
2 of 2 declarations
About Morris Richard Steven
Richard Steven Morris is the Chief Financial Officer of Passage BIO, Inc. In this role, he is responsible for the financial management of the company, including financial planning, risk management, and oversight of financial reporting. Passage BIO is an innovative company in the biotechnology field, focusing on the development of gene therapies. Mr. Morris's expertise in finance is essential to support the company's growth and sustainability.
